06-12
Guizhou Tuoxin Medical Equipment Co., Ltd. was established in 2015, with a registered capital of 1.08 million. It is a professional enterprise engaged in medical devices. The company has been issued the "Medical Device Business License" by Zunyi Municipal Food and Drug Administration. Its business scope includes: second class ECG diagnostic instruments, non-invasive monitoring instruments, respiratory function and gas analysis devices, clinical analysis instruments, etc. Three kinds of color ultrasonic imaging equipment, anesthetic breathing equipment, disposable sterile syringe, disposable infusion set, CT equipment, etc.
06-12
The medical equipment surplus continued to shrink and the growth rate remained at 10%
Imports: Rehabilitation supplies are growing rapidly from January to September, China imported medical devices from 93 countries and regions. From the regional point of view, Europe is China's medical device import market, imports of 4.29 billion US dollars, an increase of 26.52%, the proportion of 39.42%; North America was the second largest market, with imports of 3.548 billion US dollars, an increase of 20.85%, accounting for 32.59%; Asia ranked third, with imports of 2.781 billion US dollars, an increase of 12.05%, accounting for 25.55%, and the proportion of the three continents reached 97.56%.
06-12
Recent industry and company information review 1, low-cost drug catalog is about to be introduced, some traditional Chinese medicine varieties to obtain a new life It is reported that in the relevant draft documents issued by the National Development and Reform Commission to the provinces, there are 890 varieties of dosage forms included in the list of low-cost drugs, for these varieties, the National Development and Reform Commission plans to cancel the original maximum retail price formulated by the government. Instead, it is limited to the daily use cost (i.e., less than 3 yuan for chemical drugs and less than 5 yuan for proprietary Chinese drugs), and the production enterprise will set its own price according to the cost and market conditions within the range, and report to the regional price authorities for the record. 2, Shenzhen will cancel the second selection of drugs, broaden the basic drug configuration after the cancellation of drug addition last year, Shenzhen
06-12
Do you know the 6 taboos of medical device sales communication?
There must be art in communication and skill in speaking. If the sales in the conversation do not know the taboo, will cause failure; Not knowing what is appropriate creates stagnation. The author summed up the "six taboo" of sales consultant speaking from some sales failure cases for your reference.